Concepedia

Author

Niels Andreasen

Karolinska Institutet

Also Known As

Andreasen, Niels, Andreasen, Niels Peter, Niels Andreasen, Niels Peter Andreasen

175

Publications

15K

Citations

65

H-Index

74

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalUniversity of GothenburgSahlgrenska University HospitalLund University
NA

About

Niels Andreasen is an author at Karolinska Institutet specializing in medicine, neurology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

36

3.6K

2

Health Sciences

6

6

670

3

Engineering

1

1

10

4

Natural Sciences

1

1

57

5

Public Health

1

1

43

Niels Andreasen

×

95

Publications

13.8K

Citations

61

H-Index

YearCitations

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada,

New England Journal of Medicine

2018

1K

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

Niels Andreasen, Camilla Hesse, Pia Davidsson,

Archives of Neurology

1999

658

Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice

Niels Andreasen, Lennart Minthon, Pia Davidsson,

Archives of Neurology

2001

570

Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Annika Olsson, Hugo Vanderstichele, Niels Andreasen,

Clinical Chemistry

2004

438

Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values

Magnus Sjögren, Hugo Vanderstichele, Hans Ågren,

Clinical Chemistry

2001

436

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

Camilla Hesse, Lars Rosengren, Niels Andreasen,

Neuroscience Letters

2001

435

Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease

Harald Hampel, Katharina Büerger, Raymond Zinkowski,

Archives of General Psychiatry

2004

430

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway,

Archives of Neurology

2012

363

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

Hlin Kvartsberg, Flora H. Duits, Martin Ingelsson,

Alzheimer s & Dementia

2014

359

Neurochemical Aftermath of Amateur Boxing

Henrik Zetterberg, Max Albert Hietala, Michael Jonsson,

Archives of Neurology

2006

358

Page 1